Related Experiment Video

Updated: Jul 14, 2026

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture
03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?

G Garcea1, M M Manson, C P Neal

  • 1Department of Hepatobiliary and Pancreatic Surgery, The Leicester General Hospital, UK. gg43@le.ac.uk

Current Cancer Drug Targets
|May 17, 2007
PubMed

Insights

Glycogen synthase kinase (GSK) regulates cell functions, including beta-catenin and NF-kappaB. Targeting GSK offers potential for treating pancreatic cancer and related inflammation.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Glycogen synthase kinase (GSK) initially identified for glycogen metabolism.
  • GSK regulates diverse cellular functions, including beta-catenin and NF-kappaB.
  • NF-kappaB transcription factors are crucial in inflammation, oncogenesis, and development.

Purpose of the Study:

  • To explore the multifaceted roles of GSK beyond glycogen metabolism.
  • To investigate GSK's involvement in critical cellular pathways relevant to cancer.
  • To evaluate GSK as a therapeutic target for pancreatic cancer.

Main Methods:

  • Literature review of GSK's regulatory roles.
  • Analysis of GSK's involvement in beta-catenin and NF-kappaB signaling.
  • Assessment of NF-kappaB's role in pancreatic cancer pathogenesis and cachexia.

Main Results:

  • GSK is a key regulator of beta-catenin and NF-kappaB signaling pathways.
  • NF-kappaB activation is implicated in pancreatic cancer initiation and progression.
  • Inflammation mediated by NF-kappaB contributes to chemotherapy resistance and cancer cachexia.

Conclusions:

  • GSK's diverse regulatory functions position it as a significant target in oncology.
  • Targeting GSK may offer novel therapeutic strategies for pancreatic cancer, both resectable and inoperable.
  • GSK inhibition could be beneficial as an adjuvant therapy or for palliative care in advanced pancreatic cancer.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...